Article
Differentiation between pathogenic serotype 1 isolates of Marek's disease virus and the Rispens CVI988 vaccine in Australia using real-time PCR and high resolution melt curve analysis.
Journal of virological methods - 1 Jan 2013
Renz K G, Cheetham B F, Walkden-Brown S W
Abstract excerpt
Two real-time PCR assays were developed which enable quantitation and differentiation between pathogenic Australian isolates of Marek's disease virus (MDV) serotype 1 and the serotype 1 vaccine strain Rispens CVI988. The assays are based on a DNA sequence variation in the meq gene between pathogenic and vaccinal MDV1 which has been confirmed by sequencing of 20 Australian field strains of MDV. Complete...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
